Vijay Krishnamoorthy is a Cardiology physician. OpenAlex indexes 194 publications with 40,806 citations (h-index 39). By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
140 Canal View Blvd
Suite 102
Rochester, NY 146232808
Telephone
585-338-2700Registry record last updated 6 Jul 2023.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.4%Beta blocker19.6%Metoprolol Succinate56%Carvedilol24%Metoprolol Tartrate9%Atenolol8%Propranolol Hcl Er2%Nadolol1%Part D<11 patientsStatin17.4%Rosuvastatin Calcium51%Atorvastatin Calcium44%Pravastatin Sodium2%Simvastatin2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
13.4%Factor Xa inhibitor8.1%Eliquis86%Xarelto14%Part D≥123 patientsP2Y12 inhibitor4%Clopidogrel100%Part D≥77 patients+ 1 more class in this area
Metabolism & gastrointestinal
5.8%SGLT2 inhibitor3.8%Jardiance94%Farxiga6%Part D<11 patientsProton pump inhibitor1.1%Pantoprazole Sodium71%Omeprazole29%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”